UBS’s MGC Diagnostics MGCD Stock Holding History
Bought
Maintained
Sold
Other funds holding MGCD
PM
UBS's MGCD Position: Q3 2014 in Review
UBS reduced its MGC Diagnostics (MGCD) stake by 60% in Q3 2014, selling an estimated $9.1K and leaving 773 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #9536.
UBS first reported a position in MGCD in Q3 2013 and has held it in 5 quarters since. The position peaked at $161K in Q4 2013. 17 funds tracked by Wall St. Rank hold MGCD as of Q3 2014.
- UBS held 773 shares of MGC Diagnostics worth $5K as of Q3 2014.
- UBS sold 1,176 MGC Diagnostics shares in Q3 2014, an estimated $9.1K.
- MGC Diagnostics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9536 holding.
- UBS first reported a position in MGC Diagnostics in Q3 2013 and has held it in 5 quarters since.
- UBS's MGC Diagnostics position peaked at $161K in Q4 2013.
- 17 funds tracked by Wall St. Rank held MGC Diagnostics as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.